World Congress of Metabolomics to be held in South Korea for the first time, in Daegu in 2027

Daegu, South Korea, has secured the rights to host the prestigious 2027 International Congress of Metabolomics, marking a significant achievement as the first time the global event will be held in the country. The decision was announced at the 2026 congress in Buenos Aires, Argentina, where Daegu emerged victorious after a competitive bid against Australia and the Philippines.

The International Congress of Metabolomics is the world's largest academic conference dedicated to metabolomics, a crucial field in life sciences, biotechnology, and healthcare. Metabolomics involves the analysis of biochemical processes and metabolites within living organisms, playing a vital role in research for disease diagnosis, new drug development, and ensuring food safety. The congress convenes annually, rotating through different countries, and serves as a platform for leading academics and global bio-industry professionals to share the latest research trends and technological advancements.

The 2027 congress is scheduled to take place from June 20 to 24 at EXCO in Daegu. It is anticipated to attract approximately 1,500 participants from 40 countries, including researchers, scientists, and industry experts in the bio and pharmaceutical sectors. Daegu city officials estimate that the event will generate a production-induced economic ripple effect of 4.6 billion won and an added value-induced effect of 2 billion won.

Kim Jeong-gi, the acting administrative vice mayor of Daegu, hailed the successful bid as a "meaningful achievement that will showcase Daegu's capabilities in the bio-healthcare industry to the world." He expressed the city's commitment to actively supporting the congress, viewing it as a potential turning point for global research collaboration and the development of the local medical industry. The selection is expected to boost Daegu's profile as a hub for scientific research and innovation.